Scinai Immunotherapeutics (SCNI) EPS (Basic) (2015 - 2026)
Scinai Immunotherapeutics' (SCNI) quarterly EPS (Basic) came in at -$0.0 in Q2 2026, up 66.24% year-over-year from -$0.0 in Q2 2025, and up 13.01% quarter-over-quarter from -$0.0 in Q1 2026.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) EPS (Basic) (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has disclosed EPS (Basic) across 12 years of filings, most recently posting -$0.0 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 66.24% year-over-year to -$0.0; the TTM figure through Jun 2026 stood at -$0.01 (down 165.31% YoY), while the FY2025 annual figure was -$0.01, up 61.04% from the prior year.
- EPS (Basic) came in at -$0.0 for Q2 2026 at Scinai Immunotherapeutics, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.19 in Q3 2022 to a low of -$0.19 in Q4 2022.
- Average EPS (Basic) over 5 years is -$0.0, with a median of -$0.01 recorded in 2025.
- Year-over-year, EPS (Basic) soared 348.37% in 2022 and plunged 176.51% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.19 in 2022, then jumped by 81.63% to -$0.04 in 2023, then surged by 80.16% to -$0.01 in 2024, then grew by 3.0% to -$0.01 in 2025, then soared by 66.24% to -$0.0 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.0 in Q2 2026, -$0.0 in Q1 2026, and -$0.01 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Scinai Immunotherapeutics | 1.52 Bn | 1.52 Bn | -1.25 Mn | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | -0.02 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.14 |
| Mar 31, 2021 | -0.02 |